MDGL (Madrigal Pharmaceuticals, Inc.) Stock Market Reviews

crown

search

Read and share opinions on MDGL (Madrigal Pharmaceuticals, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock

MDGL

Madrigal Pharmaceuticals, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Nov 6, 2025
Madrigal Pharmaceuticals (MDGL) Losses Worsen, Profitability Forecast Sparks Debate on Valuation Narratives
Nov 6, 2025
Madrigal Q3 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Up
Nov 5, 2025
Madrigal Pharmaceuticals Inc (MDGL) Q3 2025 Earnings Call Highlights: Strong Sales Growth and ...
Nov 4, 2025
Madrigal (MDGL) Reports Q3 Loss, Tops Revenue Estimates
Nov 4, 2025
Madrigal: Q3 Earnings Snapshot
Nov 4, 2025
Madrigal (MDGL) Expected to Beat Earnings Estimates: Should You Buy?
Oct 28, 2025
Madrigal Pharmaceuticals to Release Third-Quarter 2025 Financial Results and Host Webcast on November 4, 2025
Oct 22, 2025
A Fresh Look at Madrigal Pharmaceuticals (MDGL) Valuation Following Recent Share Price Momentum
Sep 9, 2025
TD Cowen Sees Greater Upside in Madrigal (MDGL) Following Recent Rezdiffra Approval
Sep 4, 2025
Madrigal Pharmaceuticals to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
Sep 3, 2025

Reviews